Eat Right for Crohn’s Relief

Crohn’s disease, along with a similar condition called ulcerative colitis, together make up the disease category of inflammatory bowel disease. Approximately 1.6 million Americans have been diagnosed with inflammatory bowel diseases, with each year another 70,000 cases in the U.S. getting the news of this digestive complaint. Newly diagnosed Crohn’s disease patients – as well…

Breast Cancer Shouldn’t Come with Debt Collectors

The financial challenges that follow a breast cancer diagnosis can weigh heavily on a patient (and their family). Research confirms – that even more so than other cancers – breast cancer comes with considerable economic burden. These financial costs include the patient’s out-of-pocket portion for initial treatment, as well as management of treatment side effects….

Keytruda: The Good News Keeps Coming

Immunotherapy medications for cancer treatment have been a game changer for the oncology field – and none moreso than Keytruda (pembrolizumab). Keytruda initially gained FDA approval in 2014 for melanoma, with the cancer approvals expanded over the years to include advanced and metastatic cancers such as non-small cell lung cancer, head/neck cancers, Hodgkin’s lymphoma, stomach…

Walking Toward Cancer Survival

Observing the gait and walking pace of a cancer patient can serve as a sort of shorthand to assess overall patient health and even the chances of optimal treatment outcome. About a decade ago, researchers found that gait speed could be used in a general way to predict which patients might have greater challenges recovering…

Taltz: The Good News Keeps Coming

Taltz (ixekizumab, Eli Lilly), a biologic injection medication for psoriasis, shows a high level of effectiveness and the latest research demonstrates that the clear-skin response which so many patients benefit from when they use Taltz keeps up for at least four years after starting treatment. Taltz first became available in 2016 for moderate to severe…

Cancer Treatment Slowdowns

Prior authorizations can present one of the biggest obstacles to patients diagnosed with cancer. This conclusion emerged in recent discussions among experts from three groups: the American Medical Association, the American Society for Radiation Oncology, and the National Coalition for Cancer Survivorship. These experts gathered together to examine prior authorization practices and a key finding…

Psoriasis: Selecting the Right Treatment

Psoriasis continues to be a common skin condition, affecting 8 million Americans (which is about 2-3% of the population). Each year, about 150,000 new people hear the diagnosis of “psoriasis” from their doctors; after which they will then navigate a long list of treatment options. Although many patients start out with topical treatments, it’s not…

BioPlus Appeals Team: Changing “No” to “Yes!”

Do you have patients with insurance denials? Here at BioPlus we regularly transform those “no’s” into happy patients and doctors. Our dedicated appeals team steps in to do the heavy lifting of insurance appeals for doctor offices. Letting you get back to what you do best: treating patients, instead of being bogged down in back-and-forth…

Crohn’s Disease: Early is Key

For many people with Crohn’s disease, it can be a long road from the first time symptoms appear to receiving the correct diagnosis. This disease can be a bit of a mimic – with symptoms that can be mistaken for other conditions. The autoimmune-related GI inflammation of Crohn’s disease can affect different parts of the…

Missed Opportunities

By now, most Baby Boomers have probably heard the message from health experts urging them to get screened for hepatitis C infection. This demographic – born between 1945 and 1965 – have long been identified as the group at highest risk of this life-threatening disease. However, switching from a birth cohort screening to a one-time…

One in a Million? No Thanks!

Multiple sclerosis is a serious health condition faced by too many Americans. Experts recently realized that previous estimates of this disease’s prevalence were inaccurate – by a shocking amount. Multiple sclerosis is now estimated to affect 1 million people in the United States, which is nearly double the prior estimate. What changed? It’s not actually…

Serving Up Success

Immunotherapy as cancer treatment harnesses the power of a patient’s own immune system to fight cancer. This continues to be a cutting edge area of cancer research, with plenty of success stories, including immunotherapy medications such as Keytruda, Opdivo, and Tecentriq. These medications do not have the exact same effectiveness in every patient, of course….

Yoga Relief

Rheumatoid arthritis medications have come a long way in aiding those with this autoimmune joint-based condition, but they are not perfect and many patients continue to experience symptoms – even while on treatment. Regular practice of yoga exercises just might be able to fill in the gaps in terms of physical and psychological symptom relief….

Post-Treatment Financial Hardship

Cancer treatment brings many stresses to a patient and their family, not least of which is financial. Prior research has documented the monetary challenges that come with a cancer diagnosis, including the fact that someone with cancer is 2.5 times more likely than another person from the general population to file for bankruptcy. In fact,…